Kakehashi

Enterprise Systems (Healthcare) · Tokyo, Japan · Founded 2016 · Privately Held (backing)

Developer of a pharmacy experience platform designed to support patient satisfaction and work style reforms in pharmacies. Kakehashi is based in Tokyo, Japan and was founded in 2016. It was valued at $296 million at its later-stage round in Mar 2023, the last priced event on record. It has raised $219 million across 1 recorded round; the latest was a $70.3 million Series C in Mar 2023.

PMV mark · valuation
$295.6M
Oct 2026
Priced at
its later-stage round
Mar 2023
Total raised
$219.1M
Last round
Later Stage VC (Series C)
Mar 2023
How much has Kakehashi raised?
$219.1Macross 1 recorded rounds · Mar 2023 – Mar 2023

Most recently, Kakehashi raised $70.3M in its Later Stage VC (Series C) (Mar 2023).

Free account
More of Kakehashi with a free account
  • ·The complete investor list: 27 names
  • ·Watch Kakehashi: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kakehashi round by round

1 rounds
Mar 2023Later Stage VC (Series C)$70.3M▮
+ 1 more investors · free account

How much has Kakehashi raised?

Kakehashi has raised $219 million in total; 1 of its rounds is on record. The largest on record was a $70.3 million Series C in Mar 2023.

Kakehashi investors

27 investors are on record for Kakehashi, including Mitsubishi UFJ Capital, Salesforce Ventures, SMBC Venture Capital and J-Startup. By type, the record holds 10 venture capital firms and 2 private equity firms. The Series C in Mar 2023 drew 8 investors.

For fundraisers
Raising for a company like Kakehashi?

27 investors have backed Kakehashi — start your target list with the firms already writing checks in enterprise systems (healthcare).

See all 27 investors →

Frequently asked about Kakehashi

How much has Kakehashi raised?
Kakehashi has raised $219.1M in total across 1 recorded funding rounds.
When was Kakehashi's last funding round?
Kakehashi's most recent recorded round was Later Stage VC (Series C) in Mar 2023, raising $70.3M.